Elbez Y - Search Results

1

Retention and clinical response to abatacept in patients with rheumatoid arthritis: an Italian perspective.

Galeazzi M, Alten R, Chartier M, Elbez Y, Fusaro E, Le Bars M, Lorenz HM, Pagano Mariano G, Muratore M, Nüßlein HG, Patanè G. Galeazzi M, et al. Among authors: elbez y. Clin Exp Rheumatol. 2018 Sep-Oct;36(5):935-936. Epub 2018 Mar 21. Clin Exp Rheumatol. 2018. PMID: 29600933 Free article. No abstract available.

2

Abatacept retention and clinical outcomes in rheumatoid arthritis: real-world data from the German cohort of the ACTION study and a comparison with other participating countries.

Alten R, Feist E, Lorenz HM, Nüßlein H, Voll RE, Chartier M, Elbez Y, Rauch C. Alten R, et al. Among authors: elbez y. Clin Rheumatol. 2019 Nov;38(11):3049-3059. doi: 10.1007/s10067-019-04648-5. Epub 2019 Jul 12. Clin Rheumatol. 2019. PMID: 31300979

3

Abatacept retention and clinical outcomes in Austrian patients with rheumatoid arthritis: real-world data from the 2-year ACTION study.

Peichl P, Alten R, Galeazzi M, Lorenz HM, Nüßlein H, Navarro F, Elbez Y, Chartier M, Hackl R, Rauch C, Connolly SE. Peichl P, et al. Among authors: elbez y. Wien Med Wochenschr. 2020 Apr;170(5-6):132-140. doi: 10.1007/s10354-019-00710-8. Epub 2019 Oct 25. Wien Med Wochenschr. 2020. PMID: 31654156 English.

4

Up to 5-year retention of abatacept in Belgian patients with moderate-to-severe rheumatoid arthritis: a sub-analysis of the international, observational ACTION study.

Westhovens R, Connolly SE, Margaux J, Vanden Berghe M, Maertens M, Van den Berghe M, Elbez Y, Chartier M, Baeke F, Robert S, Malaise M. Westhovens R, et al. Among authors: elbez y. Rheumatol Int. 2020 Sep;40(9):1409-1421. doi: 10.1007/s00296-020-04619-z. Epub 2020 Jun 17. Rheumatol Int. 2020. PMID: 32556473 Free PMC article.

5

Real-world predictors of 12-month intravenous abatacept retention in patients with rheumatoid arthritis in the ACTION observational study.

Alten R, Mariette X, Lorenz HM, Galeazzi M, Cantagrel A, Nüßlein HG, Chartier M, Elbez Y, Rauch C, Le Bars M. Alten R, et al. Among authors: elbez y. RMD Open. 2017 Dec 29;3(2):e000538. doi: 10.1136/rmdopen-2017-000538. eCollection 2017. RMD Open. 2017. PMID: 29435360 Free PMC article.

6

Body mass index and treatment response to subcutaneous abatacept in patients with psoriatic arthritis: a post hoc analysis of a phase III trial.

McInnes IB, Ferraccioli G, D'Agostino MA, Le Bars M, Banerjee S, Ahmad HA, Elbez Y, Mease PJ. McInnes IB, et al. Among authors: elbez y. RMD Open. 2019 May 30;5(1):e000934. doi: 10.1136/rmdopen-2019-000934. eCollection 2019. RMD Open. 2019. PMID: 31245054 Free PMC article.

7

Decreased use of glucocorticoids in biological-experienced patients with rheumatoid arthritis who initiated intravenous abatacept: results from the 2-year ACTION study.

Alten R, Nüßlein H, Galeazzi M, Lorenz HM, Nurmohamed MT, Bensen WG, Burmester GR, Peter HH, Pavelka K, Chartier M, Poncet C, Rauch C, Elbez Y, Le Bars M. Alten R, et al. Among authors: elbez y. RMD Open. 2016 Feb 15;2(1):e000228. doi: 10.1136/rmdopen-2015-000228. eCollection 2016. RMD Open. 2016. PMID: 26925253 Free PMC article.

8

Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs: a descriptive analysis of data from interventional trials and the real-world setting.

Alten R, Burkhardt H, Feist E, Krüger K, Rech J, Rubbert-Roth A, Voll RE, Elbez Y, Rauch C. Alten R, et al. Among authors: elbez y. Arthritis Res Ther. 2018 Jan 2;20(1):1. doi: 10.1186/s13075-017-1488-5. Arthritis Res Ther. 2018. PMID: 29329602 Free PMC article.

9

Presence of anti-cyclic citrullinated peptide antibodies is associated with better treatment response to abatacept but not to TNF inhibitors in patients with rheumatoid arthritis: a meta-analysis.

Alemao E, Postema R, Elbez Y, Mamane C, Finckh A. Alemao E, et al. Among authors: elbez y. Clin Exp Rheumatol. 2020 May-Jun;38(3):455-466. Epub 2019 Nov 16. Clin Exp Rheumatol. 2020. PMID: 31770089 Free article.

10

Poor prognostic factors in predicting abatacept response in a phase III randomized controlled trial in psoriatic arthritis.

Mease PJ, McInnes IB, Strand V, FitzGerald O, Ahmad HA, Elbez Y, Banerjee S. Mease PJ, et al. Among authors: elbez y. Rheumatol Int. 2020 Jul;40(7):1021-1028. doi: 10.1007/s00296-020-04564-x. Epub 2020 Apr 30. Rheumatol Int. 2020. PMID: 32356115 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters